Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element

Molecular Pharmacology

Volumn 49, Issue 2, 1996, Pages 329-337

  Sterling, Kenneth ^a,b   Bresnick, Edward ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Tampa Bay Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG DNA INTERACTION; GENE SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REGULATOR GENE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL NUCLEUS; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEODOMAIN PROTEINS; HOST CELL FACTOR C1; HUMANS; KINETICS; LIVER NEOPLASMS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OCTAMER TRANSCRIPTION FACTOR-1; OLIGODEOXYRIBONUCLEOTIDES; POINT MUTATION; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0030024244     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Conney, A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42:4875-4917 (1982).
2. Gillette, J. R., D. C. Davis, and H. A. Sasame. Cytochrome P-450, and its role in drug metabolism. Annu. Rev. Pharmacol. 12:57-84 (1972).
3. Nebert, D. W., D. R. Nelson, M. A. Adesnik, M. J. Coon, R. W. Estabrook, F. J. Gonzalez, F. P. Guengerich, I. C. Gunsalus, E. F. Johnson, B. Kemper, W. Levin, I. R. Phillips, R. Sato, and M. R. Waterman. The p450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 8:1-13 (1989).
4. Nebert, D. W., and F. J. Gonzalez. P450 genes: structure, evolution, and regulation. Annu. Rev. Biochem. 56:945-993 (1987).
5. Whitlock, J. P., Jr. The regulation of gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Pharmacol. Rev. 39:147-161 (1987).
6. Sutter, T. R., Y. M. Tang, C. L. Hayes, Y.-Y. P. Wo, E. W. Jabs, X. Li, H. Yin, C. W. Cody, and W. F. Greenlee. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269:13092-13099 (1994).
7. 1-450 gene expression by dioxin. Science 227:1499-1502 (1985)
8. 1-;450 gene. Nucleic Acids Res. 13:7269-7288 (1985).
9. Hines, R. N., J. M. Mathis, and C. S. Jacob. Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis 9:599-1605 (1988).
10. Sterling, K., J. Weaver, K L. Ho, L. C. Xu, and E. Bresnick. The rat CYP1A1 negative regulatory element: biological activity and interaction with a protein(s) from liver and hepatoma cells. Mol. Pharmacol. 44:560-568 (1993).
11. Takimoto, M., J. P. Quinn, A. R. Fanna, L. M. Staudt, and D. Levens. fos/jun and octamer-binding protein with a common site in a negative element of the human c-myc gene. J. Biol. Chem. 264:8992-8999 (1989).
12. Hay, N., M. Takimoto, and J. M. A. Bishop. fos protein is present in a complex that binds a negative regulator of myc. Genes & Dev. 3:293-303 (1989).
13. Zenke, M, T. Grundstrom, H. Matthes, M. Wintzerith, C. Schatz, A. Wildeman, and P. Chambon. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 5:387-397 (1986).
14. Schirm, S., J. Jiricny, and W. Schaffner. The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. Genes & Dev. 1:65-74 (1987).
15. Ondek, B., A. Shepard, and W. Herr. Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities. EMBO J. 6:1017-1025 (1987).
16. Falkner, F. G., R. Mocikat, and H. G. Zachau. Sequences closely related to an immunoglobulin gene promoter/enhancer element occur upstream of other eukaryotic and prokaryotic genes. Nucleic Acids Res. 14:8819-8827 (1986).
17. Griffin, B. E., E. Soeda, B. G Barrell, and R. Staden. Sequence and analysis of polyoma virus DNA, in Molecular Biology of Tumor Viruses (J. Tooze, ed.). Part II, 2nd ed. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY, 831-896 (1980).
18. Fujita, T., C. Takaoka, H. Matsui, and T. Taniguchi. Structure of the human interleukin 2 gene. Proc. Natl. Acad. Sci. USA 80:7437-7441 (1983).
19. Boucher, P. D., R. J. Ruch, and R. N. Hines. Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J. Biol. Chem. 268:17384-17391 (1993).
20. Selden, R F., K. B. Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179 (1986)
21. Sanger, F., S Nicklen, and A. R. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977).
22. Roberts, S B., N. Segil, and N. Heintz. Differential phosphorylanon of the transcription factor Oct-1 during the cell cycle. Science (Washington D. C.) 253:1022-1026 (1991).
23. Segil, N., S. B. Roberts, and N. Heintz. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 binding activity. Science (Washington D. C.) 254:1814-1816 (1991).
24. Wirth, T., L. Staudt, and D. Baltimore. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (Lond.) 329:174-178 (1987).
25. Gorman, C. M., G. T. Merlino, M. C. Willingham, I. Pastan, and B. Howard. High efficiency gene transfer into mammalian cells, in DNA Cloning II: A Practical Approach (D. M. Glover, ed.). IRL Press, Oxford, 143-190 (1985).
26. Nordeen, S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-457 (1988).
27. Tanaka, M., and W. Herr. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386 (1990).
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1982).
29. Brasier, A. R., J. E. Tate, and J. F. Habener. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116-1122 (1989).
30. Groves, W. E., F. L. Davis, and B. H. Sells. Spectrophotometric determination of microgram quantities of protein without nucleic acid interference. Anal. Biochem. 22:195-210 (1968).
31. Dignam, J. D., R. M. Lebowitz, and R. G. Roeder. Accurate transcription initiation by polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489 (1983)
32. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
33. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (Lond.) 319:144-158 (1986)
34. Zwilling, S., A. Annweiler, and T. Wirth. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res. 22:1655-1662 (1994).
35. Zwilling, S., H. Konig, and T. Wirth. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14:1198-1208 (1995).
36. Cleary, M. A., and H. Herr. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain. Mol. Cell Biol. 15:2090-2100 (1995).
37. Nebert, D. W. Drug-metabolizing enzymes in ligand modulated transcription. Biochem. Pharmacol. 47:25-37 (1994).
38. Boucher, P. D., and R. N. Hines. In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. Carcinogenesis 16:383-392 (1995).
39. Sogawa, K., A. Fujisawa-Sehara, M. Yamane, and Y. Fujii-Kuriyama. Location of regulatory elements responsible for drug indiction in the rat cytochrome P-450c gene. Proc. Natl Acad. Sci. USA 83: 8044-8048 (1986).